Scientists Thought They Had Measles Cornered. They Were Wrong. by ...
Following intensive vaccination efforts, measles cases plunged across the world. Now clusters of new infections — some linked, […]
NYT
Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again by ...
Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout […]
From Bubble Memory to Hot Spots and a Fly Rod ...
David E. Sanger, a national security correspondent, recounts his gear from the computers in use when he joined […]
Express Scripts Offers Diabetes Patients a $25 Cap for Monthly ...
Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the […]
Apple AirPods Review: The Perfect Earbuds, Except They Don’t Last ...
Sleek and convenient, Apple’s wireless earbuds are an engineering marvel. But they are difficult and expensive to maintain. […]
Cholera Is Spreading in Mozambique, and It’s Far From the ...
About two million people are displaced, cholera has broken out, and malaria is expected. But doses of cholera […]
Drug Sites Upend Doctor-Patient Relations: ‘It’s Restaurant-Menu Medicine’ by NATASHA ...
A new wave of websites turns physicians into mere gatekeepers for popular lifestyle drugs, increasing public health risks, […]
With Bitcoin’s Stumble, ‘the Smart Money Knows That Crypto Is ...
Cryptocurrency enthusiasts thought big financial institutions would lend credibility to their work. But last year’s crash has cooled […]
Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for ...
Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in […]
One Day There May Be a Drug to Turbocharge Your ...
Published: April 2, 2019 at 02:00AM from NYT Health https://ift.tt/2I6spSU